Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit

We aimed to determine microbial signature linked with lung cancer (LC) diagnosis and to define taxa linked with durable clinical benefit (DCB) of advanced LC patients. Stool samples for microbial 16S amplicon sequencing and clinical data were collected from 75 LC patients (50 of which were treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Haberman, Yael, Kamer, Iris, Amir, Amnon, Goldenberg, Sapir, Efroni, Gilat, Daniel-Meshulam, Inbal, Lobachov, Anastasiya, Daher, Sameh, Hadar, Rotem, Gantz-Sorotsky, Hadas, Urban, Damien, Braun, Tzipi, Bar, Jair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898251/
https://www.ncbi.nlm.nih.gov/pubmed/36737654
http://dx.doi.org/10.1038/s41598-023-29136-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898251/
https://www.ncbi.nlm.nih.gov/pubmed/36737654
http://dx.doi.org/10.1038/s41598-023-29136-4

Ejemplares similares